Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Nuclear envelope-related muscular dystrophies, in particular those referred to as laminopathies, are relatively novel and unclear diseases, also considering the increasing number of mutations identified so far in genes of the nuclear envelope. As regard LMNA gene, only tentative relations between phenotype, type and localization of the mutations have been established in striated muscle diseases, while laminopathies affecting adipose tissue, peripheral nerves or progerioid syndromes could be linked to specific genetic variants. This study describes the biochemical phenotype of neuromuscular laminopathies in samples derived from LMNA mutant patients. Since it has been reported that nuclear alterations, due to LMNA defects, are present also in fibroblasts from Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy patients, we analyzed 2D-maps of skin fibroblasts of patients carrying 12 different LMNA mutations spread along the entire gene. To recognize distinctive proteins underlying affected biochemical pathways, we compared them with fibroblasts from healthy controls and, more importantly, fibroblasts from patients with non-lamin related neuromuscular disorders. We found less abundance of cytoskeletal/structural proteins, confirming a dominant role for Lamin A/C in structural support of nuclear architecture. Interestingly, we also established significant changes in the expression of proteins involved in cellular energy production and oxidative stress response. To our knowledge, this is the first report where proteomics was applied to characterize ex-vivo cells from LMNA patients, suggesting that this may represent a new approach to better understand the molecular mechanisms of these rare diseases and facilitate the development of novel therapeutic treatments.

Original languageEnglish
Pages (from-to)970-979
Number of pages10
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1822
Issue number6
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Cytoskeletal Proteins
Energy Metabolism
Fibroblasts
Mutation
Nuclear Envelope
Proteins
Familial Partial Lipodystrophy
Emery-Dreifuss Muscular Dystrophy
Lamin Type A
Genes
Phenotype
Striated Muscle
Muscular Dystrophies
Rare Diseases
Peripheral Nerves
Proteomics
Adipose Tissue
Oxidative Stress
Skin
Therapeutics

Keywords

  • Laminopathies
  • Mass spectrometry
  • Muscular dystrophy
  • Proteomics
  • Skin fibroblasts

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

@article{9c7ac0005d534f21bed59d29af6ac410,
title = "Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers",
abstract = "Nuclear envelope-related muscular dystrophies, in particular those referred to as laminopathies, are relatively novel and unclear diseases, also considering the increasing number of mutations identified so far in genes of the nuclear envelope. As regard LMNA gene, only tentative relations between phenotype, type and localization of the mutations have been established in striated muscle diseases, while laminopathies affecting adipose tissue, peripheral nerves or progerioid syndromes could be linked to specific genetic variants. This study describes the biochemical phenotype of neuromuscular laminopathies in samples derived from LMNA mutant patients. Since it has been reported that nuclear alterations, due to LMNA defects, are present also in fibroblasts from Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy patients, we analyzed 2D-maps of skin fibroblasts of patients carrying 12 different LMNA mutations spread along the entire gene. To recognize distinctive proteins underlying affected biochemical pathways, we compared them with fibroblasts from healthy controls and, more importantly, fibroblasts from patients with non-lamin related neuromuscular disorders. We found less abundance of cytoskeletal/structural proteins, confirming a dominant role for Lamin A/C in structural support of nuclear architecture. Interestingly, we also established significant changes in the expression of proteins involved in cellular energy production and oxidative stress response. To our knowledge, this is the first report where proteomics was applied to characterize ex-vivo cells from LMNA patients, suggesting that this may represent a new approach to better understand the molecular mechanisms of these rare diseases and facilitate the development of novel therapeutic treatments.",
keywords = "Laminopathies, Mass spectrometry, Muscular dystrophy, Proteomics, Skin fibroblasts",
author = "Cinzia Magagnotti and Angela Bachi and Gianpaolo Zerbini and Elena Fattore and Isabella Fermo and Michela Riba and Previtali, {Stefano C.} and Maurizio Ferrari and Annapaola Andolfo and Sara Benedetti",
year = "2012",
month = "6",
doi = "10.1016/j.bbadis.2012.01.014",
language = "English",
volume = "1822",
pages = "970--979",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers

AU - Magagnotti, Cinzia

AU - Bachi, Angela

AU - Zerbini, Gianpaolo

AU - Fattore, Elena

AU - Fermo, Isabella

AU - Riba, Michela

AU - Previtali, Stefano C.

AU - Ferrari, Maurizio

AU - Andolfo, Annapaola

AU - Benedetti, Sara

PY - 2012/6

Y1 - 2012/6

N2 - Nuclear envelope-related muscular dystrophies, in particular those referred to as laminopathies, are relatively novel and unclear diseases, also considering the increasing number of mutations identified so far in genes of the nuclear envelope. As regard LMNA gene, only tentative relations between phenotype, type and localization of the mutations have been established in striated muscle diseases, while laminopathies affecting adipose tissue, peripheral nerves or progerioid syndromes could be linked to specific genetic variants. This study describes the biochemical phenotype of neuromuscular laminopathies in samples derived from LMNA mutant patients. Since it has been reported that nuclear alterations, due to LMNA defects, are present also in fibroblasts from Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy patients, we analyzed 2D-maps of skin fibroblasts of patients carrying 12 different LMNA mutations spread along the entire gene. To recognize distinctive proteins underlying affected biochemical pathways, we compared them with fibroblasts from healthy controls and, more importantly, fibroblasts from patients with non-lamin related neuromuscular disorders. We found less abundance of cytoskeletal/structural proteins, confirming a dominant role for Lamin A/C in structural support of nuclear architecture. Interestingly, we also established significant changes in the expression of proteins involved in cellular energy production and oxidative stress response. To our knowledge, this is the first report where proteomics was applied to characterize ex-vivo cells from LMNA patients, suggesting that this may represent a new approach to better understand the molecular mechanisms of these rare diseases and facilitate the development of novel therapeutic treatments.

AB - Nuclear envelope-related muscular dystrophies, in particular those referred to as laminopathies, are relatively novel and unclear diseases, also considering the increasing number of mutations identified so far in genes of the nuclear envelope. As regard LMNA gene, only tentative relations between phenotype, type and localization of the mutations have been established in striated muscle diseases, while laminopathies affecting adipose tissue, peripheral nerves or progerioid syndromes could be linked to specific genetic variants. This study describes the biochemical phenotype of neuromuscular laminopathies in samples derived from LMNA mutant patients. Since it has been reported that nuclear alterations, due to LMNA defects, are present also in fibroblasts from Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy patients, we analyzed 2D-maps of skin fibroblasts of patients carrying 12 different LMNA mutations spread along the entire gene. To recognize distinctive proteins underlying affected biochemical pathways, we compared them with fibroblasts from healthy controls and, more importantly, fibroblasts from patients with non-lamin related neuromuscular disorders. We found less abundance of cytoskeletal/structural proteins, confirming a dominant role for Lamin A/C in structural support of nuclear architecture. Interestingly, we also established significant changes in the expression of proteins involved in cellular energy production and oxidative stress response. To our knowledge, this is the first report where proteomics was applied to characterize ex-vivo cells from LMNA patients, suggesting that this may represent a new approach to better understand the molecular mechanisms of these rare diseases and facilitate the development of novel therapeutic treatments.

KW - Laminopathies

KW - Mass spectrometry

KW - Muscular dystrophy

KW - Proteomics

KW - Skin fibroblasts

UR - http://www.scopus.com/inward/record.url?scp=84859060784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859060784&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2012.01.014

DO - 10.1016/j.bbadis.2012.01.014

M3 - Article

C2 - 22326558

AN - SCOPUS:84859060784

VL - 1822

SP - 970

EP - 979

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 6

ER -